EFFICACY AND TOLERABILITY OF PROLONGED VALPROATE (DEPAKINE® CHRONOSPHEREТМ) FOR FIRST LINE THERAPY IN ADULT PATIENTS WITH EPILEPSY
Abstract
About the Authors
Ye. D. Belousova
FGBU VPO MNII of pediatry and child surgery, Ministry of Health and Social Development of Russia
Russian Federation
Russian Federation
G. N. Avakyan
GBOU VPO Russian National Investigational Medical University named after N.I. Pirogov, Ministry of Health and Social Development of the Russian Federation (Moscow)
Russian Federation
Russian Federation
References
1. Landmark CJ, Fossmark H, Larsson PG, Rytter E, Johannessen SI. Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population. EpilepsyRes.; 2011; V.95(1-2); P.51-9.
2. Карлов В.А. Антиэпилептические препараты. Эпилепсия у детей и взрослых женщин и мужчин. Руководство для врачей. Москва; Медицина; 2010; стр.577-585
3. Marson AG, Al-Kharusi AM, Alwaidh M et al. The SANAD study of effectiveness of valproate, lamotrigine or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet; 2007; V.369; P.1016–1026.
4. Jedrzejzak J., Kunchikova M. and Margureanu S. An observational study of first-line valproate monotherapy in focal epilepsy. EuropeanJournalofNeurology; 2008; V.15; P. 66-72.
5. Белоусова Е.Д. Российское наблюдательное исследование эффективности и переносимости Депакина Хроно в качестве первой монотерапии парциальной эпилепсии. Неврология, нейропсихиатрия, психосоматика; 2010; том 3; стр. 47-52.
6. Dulac O. and Alvarez J.-C. Bioequivalence of a New Sustained-Release Formulation of Sodium Valproate, Valproate ModifiedRelease Granules, Compared with Existing Sustained-Release Formulations After Onceor Twice-Daily Administration. Pharmacotherapy; 2005; V.25; N1; P.35 – 41.
7. Белоусова Е.Д., Ермаков А.Ю. Применение Депакина Хроносфера в качестве первой монотерапии для лечения эпилепсии у детей. Неврология, нейропсихиатрия, психосоматика, 2010, N3; стр. 52-57
8. Engel J.R., A Proposed Diagnostic Schema for People with Epileptic Seizures and with Epilepsy. Epilepsia; 2001; V. 42 (6); V. 796-803.
9. Депакин Хроносфера. Инструкция по применению препарата. Рег. Номер: ЛСР-005197/08 от 03.07.2008.
10. Kwan P., Arzimanoglou A. Berg A. Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies Epilepsia; 2010; V.51(6); P.1069–1077
11. Akiyama T., Kobayashi K., Ogino T. et al.A population-based survey of childhood epilepsy in Okayama Prefecture, Japan: reclassification by a newly proposed diagnostic scheme of epilepsies in 2001. Epilepsy Res.; 2006; V.70; Suppl 1; P.34-40.
Review
For citations:
Belousova Y.D., Avakyan G.N. EFFICACY AND TOLERABILITY OF PROLONGED VALPROATE (DEPAKINE® CHRONOSPHEREТМ) FOR FIRST LINE THERAPY IN ADULT PATIENTS WITH EPILEPSY. Epilepsy and paroxysmal conditions. 2012;4(2):48-54. (In Russ.)
Views: 820
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
